Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Environmental Factors in Pediatric Systemic Autoimmune Diseases

Lisa G. Rider, MD, & Frederick W. Miller, MD, PhD  |  Issue: March 2017  |  March 20, 2017

A role for antibiotic usage, particularly in the first two years of life, but up to the date of diagnosis with JIA, was also observed in a Finnish national registry case-control study based on antibiotic prescription reimbursement records. The study also found a higher risk of JIA was associated with more courses of antibiotic use and with certain antibiotics, including lincosamides and cephalosporins.18 An altered fecal microbiome, including a reduction in Firmicutes and increase in Bacteroides species, was reported at diagnosis in the stool samples of children with JIA compared with healthy control children.19

A recent study of children with JIA and anti-CCP autoantibodies found they were more likely to have tender/bleeding gums on oral health history and higher antibody titers to Porphyromonas (P.) gingivalis and P. intermedia, suggesting a role for periodontitis and the oral microbiome in a subgroup of patients with JIA.20

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

A large case-control Swedish registry found an association between a higher risk for JIA and the number of hospitalizations for infection in the first year of life, including for respiratory, gastrointestinal or skin/soft-tissue infections21 (see Table 2). However, a smaller U.S. playmate-matched case-control questionnaire study did not find this association with hospitalization for infection in the first year of life, nor with attendance at daycare for those younger than 6 years of age.22

Several analyses of demographic factors suggest smaller (vs. larger) family size and urban environments are modifiers of JIA risk, but the data are mixed. A higher risk of JIA was associated with being a single child in a family and with higher parental income in a national Danish case-control study of incident JIA cases, which used socioeconomic registry data to extract demographic and socioeconomic factors (see Table 2, Demographics).5

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Having any siblings, particularly three or more siblings, was protective for JIA risk in an Australian case-hospital control questionnaire study.23 No effect of sibling number was reported in the Swedish case-control registry study or birth order in the Seattle case-control study.21,22 These first two studies are consistent with the hygiene hypothesis, but the latter two are not.

The Danish national registry case-control study found a higher risk of JIA with urban dwelling compared with living on a farm (see Table 2, Demographics).5 However, the Seattle case-control study did not find an association with rural residence or with the frequency or type of household pets.22

A German case-hospital control questionnaire study saw no effect of living in an urban vs. rural area, living on a farm in the first year of life or exposure to farm animals or pets during infancy on development of oligoarticular JIA.25

Page: 1 2 3 4 5 6 7 8 | Single Page
Share: 

Filed under:Conditions Tagged with:air pollutionAutoimmune diseaseenvironmental factorgeneticInfectionJuvenile idiopathic arthritisKawasaki diseasepatient carePediatricsRheumatic DiseaserheumatologistriskSmoking

Related Articles

    What Adult Rheumatologists Need to Know about Juvenile Arthritis

    May 1, 2013

    How to recognize distinctions between pediatric and adult arthritis

    Air Pollution: Is There an Association with Rheumatic Disease?

    December 17, 2015

    Interactions between an individual’s genetic background and their exposure to environmental factors are thought to result in a cascade of immune reactions, ultimately leading to the development of autoimmune diseases such as rheumatoid arthritis (RA), juvenile idiopathic arthritis (JIA), systemic lupus erythematosus (SLE) and juvenile dermatomyositis.1,2 For example, an environmental factor that conclusively affects susceptibility…

    An Overview of Pediatric, Noninfectious Uveitis

    October 18, 2018

    Uveitis is an inflammation of the uvea, which comprises the iris, ciliary body and choroid. Uveitis can lead to ocular damage and complete visual loss. Noninfectious etiologies for uveitis are the most common in the U.S.1 The estimated incidence of uveitis ranges from 25–52 per 100,000 in adults and five per 100,000 in children. The…

    A Possible Diagnostic Tool: RheumMadness 2022 AI: JIA Subtypes Scouting Report

    February 14, 2022

    Machine learning is a tool that may help pediatric rheumatologists distinguish between different subtypes of juvenile idiopathic arthritis (JIA) and predict treatment response.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences